PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Advanced Basal Cell Carcinoma: An Exploration of Clinical Challenges and What the Future Could Hold
Visit https://www.peervoice.com/GSX860 to view the entire programme with slides. After completing “Advanced Basal Cell Carcinoma: An Exploration of Clinical Challenges and What the Future Could Hold”, participants will be able to: Recognise the challenges and limitations of current systemic treatment strategies for advanced basal cell carcinoma (aBCC) and how these impact patient outcomes; Describe the potential therapeutic targets related to aBCC and the emerging clinical data for these novel therapies as second-line treatment; Translate the evidence for emerging therapeutic strategies; Propose a treatment paradigm for patients with aBCC who have progressed on or are intolerant to prior Hedgehog pathway inhibitor therapy.